Pharmaceutical composition, method of preparation and methods of treating aches/pains
OwnerNicholas DeSica, Muhammed Ali +1inventors
InventorsNicholas DeSica, Muhammed Ali, Richard Li
Life of this patent
Estimating the term…
Abstract
Provided are methods and compositions useful for treating/aches and/or pains. The composition includes ibuprofen and arginine in a clear stable aqueous ethanol vehicle that is stable at room temperature for at least 6 months without separation or precipitation. The composition is effective for delivering ibuprofen directly through the mucosal or buccal tissue without passing through the GI tract.
Claims14
A stable aqueous ibuprofen composition comprising:
- ibuprofen;
- glycerin;
- arginine in an amount sufficient to enhance the solubility of said ibuprofen and stabilize said composition;
- ethanol;
- and
- the balance water;
- said stable aqueous ibuprofen composition having a pH of about 7.0-8.0, and where said composition is a clear composition having said ibuprofen dissolved in solution and dispersed in suspension and having a particle size of 500 nm or less.
A stable aqueous sublingual pharmaceutical composition obtained by a process, comprising the steps of:
- mixing ibuprofen powder in a mixture comprising water, alcohol and glycerin to form a first ibuprofen mixture;
- preparing a second mixture of salt, sugar, an emulsifier, arginine and a preservative in water and glycerin and mixing under vacuum of 10-14 psi and high shear;
- and
- thereafter mixing said first ibuprofen mixture and said second mixture under vacuum of 10-14 psi and high shear to produce said stable aqueous pharmaceutical composition wherein the ibuprofen in said stable pharmaceutical composition has a particle size of 500 nanometers or less.
A method of treating pain in a patient in need thereof comprising
- administering an aqueous ibuprofen composition directly to the sublingual or buccal tissue of a patient in an amount to deliver ibuprofen to the bloodstream, said ibuprofen composition being a stable, clear composition having ibuprofen in solution and/or suspension and where said ibuprofen has a particle size of about 500 nm or less.
Dependencies are inferred from the claim text.